US2005003436A1PendingUtilityA1

Release of intracellular material

Priority: Aug 25, 1995Filed: Aug 3, 2004Published: Jan 6, 2005
Est. expiryAug 25, 2015(expired)· nominal 20-yr term from priority
C12N 15/1003Y10T436/143333C12Q 1/6844C12N 13/00C12Q 1/6806C12N 1/06
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Intracellular material is released from bacterial, yeast, plant, animal, insect or human cells by the application of a low voltage such as 1 to 10 V to a suspension containing the cells. The conditions may be selected such that DNA released from the cells is electrochemically denatured so as to be available for use in an amplification procedure.

Claims

exact text as granted — not AI-modified
1 - 17  (cancelled)  
     
     
         18 . A process of amplifying a target sequence of nucleic acid comprising denaturation, hybridisation, and replication of nucleic acid wherein the nucleic acid is released from a cell by a method comprising applying a voltage of not more than 50 volts to a suspension containing said cell or cells, and said denaturation is conducted by subjecting a solution containing said nucleic acid to a voltage applied between electrodes for a period of up to 2 minutes under conditions such as to convert at least a portion of the nucleic acid to a wholly or partially single-stranded form in the solution.  
     
     
         19 . An amplification process as claimed in  claim 18 , wherein the amplification procedure is PCR or LCR.  
     
     
         20 . A process for replicating a nucleic acid which comprises: releasing double stranded nucleic acid from cells by a method comprising applying a voltage of nor more than 50 volts to a suspension containing said cell or cells, separating the strands of a sample double-stranded nucleic acid in solution under the influence of an electrical voltage applied to the solution from an electrode; hybridising the separated strands of the nucleic acid with at least one oligonucleotide primer that hybridises with at least one of the strands of the denatured nucleic acid; synthesising an extension product of the or each primer which is sufficiently complementary to the respective strand of the nucleic acid to hybridise therewith; and separating the or each extension product from the nucleic acid strand with which it is hybridised to obtain the extension product.  
     
     
         21  (canceled)

Join the waitlist — get patent alerts

Track US2005003436A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.